摘要
目的观察探讨盐酸氟桂利嗪预防性治疗偏头痛性眩晕的疗效。方法选取临床确诊的偏头痛性眩晕患者46例,将其分为观察组及对照组。观察组给予盐酸氟桂利嗪胶囊(10mg,QN)+甲磺酸培他司汀片(6mg,TID)联合口服;对照组给予甲磺酸培他司汀片(6mg,tid)单独口服。观察开始治疗3个月内头痛和眩晕发作的严重程度和发作的次数。结果治疗后3个月内,观察组较对照组在头痛发和眩晕发作的程度和次数上均有有明显减轻,差异具有统计学意义(P>0.05)。结论盐酸氟桂利嗪预防性治疗偏头痛性眩晕具有明确疗效。
Objective To observe the effect of Flunarizine hydrochloride in treating migrainous vertigo （MV）. Methods Totally 46 patients with MV were divied into treatment group and control group. Flunarizine hydrochloride capsules （10mg, QN） ＋ Betahistine mesilate tablets （6mg, TID） were used in treatment group, and Betahistine mesilate tablets （6mg, TID） in control group. The number of episodes and severity of attack about MV were observed within 3 months of treatment. Results The number of episodes and severity of attack about MV in treatment group was lighter than that of the control group with statistically significant difference （ P 〉 0.05 ）. Conclusions The effect of preventive treatment of Flunarizine hydrochloride for MV is clear.
出处
《医药论坛杂志》
2012年第11期34-35,37,共3页
Journal of Medical Forum
关键词
盐酸氟桂利嗪
偏头痛性眩晕
治疗
Flunarizine hydrochloride
Migrainous vertigo （ MV ）
Treatment
